Two cancer vaccines from Hong Kong-based Sequencio Therapeutics have been selected for presentation at a major US conference, as companies bet on therapies based on ribonucleic acid (RNA) to deliver breakthroughs in cancer treatment.
Sequencio, a subsidiary of Li Ka-shing-backed CK Life Sciences,…
HONG KONG SAR — Media OutReach Newswire — 4 November 2026 — Sequencio Therapeutics Company Limited (“Sequencio”), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. (“CK Life Sciences”), today...